Zongertinib is a human HER2-selective tyrosine kinase inhibitor, a novel TK that is highly selective for covalent binding to the HER2 tyrosine kinase domain (TKD).Zongertinib exhibits antitumor activity with inhibitory effects on pHER2 and EGF.
Molecular Weight:
535.6
Purity:
98.24%
CAS Number:
[2728667-27-2]
Formula:
C29H29N9O2
Target:
HER|||Tyrosine Kinases|||c-Met/HGFR
T69534
* VAT and and shipping costs not included. Errors and price changes excepted